5 To Advance Health Equity, Disrupt the Prescription Drug Market - Politics Information

To Advance Health Equity, Disrupt the Prescription Drug Market


By Amy Hinojosa


Hispanic Americans are the least insured racial or ethnic group in the United States. Roughly 20% don't have health coverage. That's compared to just 6% of the non-Hispanic white population.

As a leader in the Latina community, I'm calling on my fellow Americans to join me in forging bold and disruptive change to the enduring inequities in our healthcare system.

For decades, our institutions and policies have profoundly underserved members of historically marginalized communities, especially Black and Hispanic populations. Finding ways to upend the status quo and build a more equitable system needs to be a priority.

Prescription drug delivery systems should be at the top of the list for major overhaul. By bringing greater transparency to pricing, insurance practices, and middlemen entities such as pharmacy benefits managers (PBMs), policymakers can clear the path to affordable life-saving medicines and level the playing field for health equity.

Simple access to a prescribed medication regimen is a serious public health problem, resulting in as many as 125,000 deaths each year and at least one in ten hospitalizations. For Black and Hispanic populations, they are 7.5 percentage points lower in their ability to maintain a consistent medication regimen. That's why overhauling how medicines are paid for and distributed in our country could have a life-changing impact on the health of communities of color.

A venture recently launched by the famed entrepreneur Mark Cuban could point the way toward an even bigger push for reform. With his new online pharmacy, the Mark Cuban Cost Plus Drug Company, Cuban intends to shake up the industry by delivering generic medications at cost plus a 15 percent fee. That will make some medications available at lower prices than patients can get through their insurance plans.

Under the current system, the actual price insurers pay for many drugs is often kept secret from patients. This enables coverage providers to significantly inflate out-of-pocket drug costs without consumers ever realizing. Cuban's model eliminates such secretive pricing strategies, giving patients a much fairer deal as a result.

It's a great first step in the direction of an even bigger but necessary disruption: exposure and elimination of the back door dealings of PBMs and insurers in the brand-name drug market. Right now, it's common for these firms to secure massive discounts on brand-name drugs from pharmaceutical companies, totaling more than $175 billion in 2019.

In some cases, this can lead to lower insurance premium costs. But that means little to patients who are sick and need medications requiring expensive out-of-pocket payments. The drug maker discounts aren't reaching the consumers who need them most. In 2020, the majority of the nation's spending on brand-name drugs went to companies like insurers and PBMs, not to drug companies who invent and manufacture medicines.

Cutting out these middlemen -- or, at the very least, forcing them to share their massive drug discounts with patients -- is precisely the kind of revolutionary reform that could immediately flip some of the inequities in our health system. Mark Cuban took the ball to the goal line by demanding transparency throughout the prescription drug supply chain. Congress can get the win for consumers and families across the country by following his playbook.

Amy Hinojosa is the president and CEO of MANA, a national Latina organization, the oldest and largest Latina membership organization in the United States and founding member of the Health Equity Collaborative. This piece originally ran in the Focus Daily News.

More Resources


03/29/2024
2024, an Election About Elections
The new poll out from Fox News has a number of intriguing findings.

more info


03/29/2024
The Overlooked Truths About Biden's Age
In terms of optics and in terms of energy, I wish President Biden were younger. There's no point in pretending

more info


03/29/2024
Biden, Obama & Clinton Join Forces in NY
Thursday on the RealClearPolitics radio show (Monday through Friday at 6:00 p.m. EDT on SiriusXM's P.O.T.U.S. Channel 124), Carl Cannon, Tom Bevan and Emily Jashinsky discuss: Joe Lieberman's passing, Bobby Kennedy Jr.'s appeal to voters, the environment of victimization culture, Sam Bankman-Fried's 25-year prison sentence, and James Carville's riff on "preachy" Democrats.

more info


03/29/2024
Meddlers for RFK Jr.
Democrats may get bitten by a tactic they use to great effect in GOP primaries.

more info


03/29/2024
Will RFK Jr.'s Support for Israel Limit His Appeal on Left?
Robert F. Kennedy Jr.'s independent presidential campaign goes to considerable lengths to profess its potential appeal to people across the partisan and ideological landscape.

more info


03/29/2024
Joe Lieberman's Last Words on Israel
A warning to Biden that he risks losing the votes of Jewish Democrats like us.

more info


03/29/2024
A Senator Who Loved To Kibitz


more info


03/29/2024
Behind Scenes Stories of Censorship
Dave Rubin of "The Rubin Report" hosts a panel with the winners of the first RealClearPolitics Samizdat Prize -- "Twitter Files" journalist Matt Taibbi, "Great Barrington Declaration" co-author Dr. Jay Bhattacharya, and NY Post reporter and "Laptop From Hell" author Miranda Devine. The three were chosen for their bravery in resisting censorship. They discuss the cost of taking a stand as well as the future of free speech and online discourse.

more info


03/29/2024
Bidenomics Is Making China Angry. That's OK
A persistent theme in Republican campaigning these past few years has been the effort to portray Democrats in general, and

more info


03/29/2024
Biden's Boss Tightens the Screws


more info


03/29/2024
The Fight To Flip the House Just Got Harder for Dems


more info


03/29/2024
In 2024, Digital Is Everything in Politics


more info


03/29/2024
Comer Sums Up His 'Evidence' of Biden Crimes. It's Scant


more info


03/29/2024
WaPo's Lead Liar Waves Away Evidence of Biden Corruption
Glenn Kessler pretended to 'dissect' Rep. James Comer's comments but did not challenge any of the evidence the Republican mentioned.

more info


03/29/2024
Sam Bankman-Fried's Dream Came True


more info



Custom Search

More Politics Articles:

Related Articles

Pelosi's Drug Plan Would Kill Innovation -- and Hope


"Help is on the way." That's what House Speaker Nancy Pelosi told American patients when she unveiled her sweeping plan to lower drug prices.

Solving the Looming Superbug Crisis Will Require Bold Action From Congress


Antimicrobial resistance killed upwards of 160,000 Americans in 2010. More and more infections are becoming resistant to antibiotics and antifungals — and while Americans know this is a growing problem, few know how bad it already is.

One Nation Under God?


"I had no idea how critical religion is to the functioning of democracy." So said a Marxist economist from China conversing with Harvard Professor, Clayton Christensen.

The Art of the Budget Deal: White House and Congress Cooperate?


Last week, President Donald Trump and House Speaker Nancy Pelosi announced a two-year budget deal that suspends the debt ceiling, and will raise federal spending $320 billion over amounts agreed to during the Obama years.

Showdown with the Ayatollahs: A Dangerous Situation


Yesterday, President Donald Trump imposed more economic sanctions on Iran. In response, Iranian officials denounced the sanctions. Does diplomacy have a chance in this situation? Or is war inevitable?

AOC's Ravings Against Billionaires


"No one ever makes a billion dollars. You take a billion dollars."

House Drug Bill Dooms Medical Research


House lawmakers recently voted to pass the "Lower Drug Costs Now Act," which would enable government officials to set the price of lifesaving medicines. The bill would reduce pharmaceutical companies' revenues by a staggering $1 trillion over the coming decade.

To Boost the Economy, Fight Chronic Disease


To understand the health of an economy, look at the health of those who participate in it.

Animal Rights Groups Choose Coronavirus Over Your Safety


Top U.S. health officials recently delivered a sobering message: Americans must prepare for the inevitable spread of the coronavirus within the United States. So far in the U.S., 11 people have died. The virus has claimed the lives of more than 3,200 people and infected over 95,000 worldwide.

How To Draw On The Power Of Perseverance During COVID-19


People's ability to keep up their spirits is being put to the test during the COVID-19 pandemic. Health concerns, job concerns, and disruptions to day-to-day routines have combined to create a challenging situation for Americans and for people throughout the world.

Trump's "Buy America" Plan Will Backfire


In response to the ongoing coronavirus pandemic, the Trump administration wants to quarantine American manufacturing. At any time now, the president could sign an executive order aimed at returning the pharmaceutical supply chain to the United States.

Exercising Bayh-Dole March-in Rights Would Handicap COVID-19 Innovation


Scientists across America are working hard to develop treatments for and vaccines against COVID-19. Unfortunately, several activist groups are making their jobs harder.

Academic Research Can't End the Pandemic Without Private Backing


Scientists at Yale University and scores more research institutions nationwide are working around the clock to identify potential avenues of diagnosing, preventing, and treating COVID-19. Many of these projects are backed by the federal government's National Institutes of Health. Any one of them could lead to a game-changing insight that helps end this pandemic.

Natural Gas Will Power Our Economic Recovery


After months of sheltering in place, Americans are finally returning to their favorite restaurants, stores, and barbershops.

"All the News That's Fit to Print," As Long As It Promotes a Progressive Agenda


One hundred and 23 years later, the New York Times still boasts of its alleged objectivity with the phrase "All the News That's Fit to Print" located on the upper left-hand corner of its front page. The slogan was the idea of the paper's owner Adolph S. Ochs in 1897. He meant it as "a declaration of the newspaper's intention to report the news impartially," according to the language arts Website ReadWriteThink.